Results 101 to 110 of about 22,851 (227)

Thromboprophylaxis in general surgery (with a Synopsis of Venous Thromboembolism) [PDF]

, 2022
Venous thromboprophylaxis aims at reducing avoidable morbidity, death and chronic ill health from hospital associated venous thromboembolism (VTE).
Mbah , N
core  

Prevention of venous thromboembolism in cancer patients: current approaches and opportunities for improvement

Oncology Reviews, 2011
Venous thromboembolism (VTE), a common complication in patients with cancer, is associated with increased risk of morbidity, mortality, and recurrent VTE.
Alpesh N. Amin, Steven B. Deitelzweig
doaj   +1 more source

Antepartum and Postpartum Thromboprophylaxis Preferences: Insights From a Single‐Center Survey

Health Science Reports
Background Venous thromboembolism (VTE) is a significant contributor to maternal morbidity and mortality worldwide. Thromboprophylaxis guidelines are critical for VTE prevention, yet the optimal implementation of risk‐appropriate thromboprophylaxis ...
Zwidorulwa Rabali, Haroun A. Rhemtula, Elise Schapkaitz   +2 more
doaj   +1 more source

Factors influencing hospice thromboprophylaxis policy: a qualitative study

, 2008
Despite level 1 evidence supporting the use of low–molecular weight heparin thromboprophylaxis in hospitalised cancer patients, only 7% of specialist palliative care units (SCPU) have thromboprophylaxis guidelines. The reasons for this are unclear. To
Noble, Simon Ian Robert, Finlay, Ilora Gillian, Nelson, Annmarie   +2 more
core   +1 more source

Thromboprophylaxis practice patterns in two Western Australian teaching hospitals

Haematologica, 2004
BACKGROUND AND OBJECTIVES: Evidence-based international guidelines recommend that all patients undergoing elective hip or knee arthroplasty receive thromboprophylaxis with low-molecular-weight heparin or adjusted-dose warfarin.
JW Eikelboom, A Mazzarol, DJ Quinlan, R Beaver, J Williamson, Q Yi, GJ Hankey, The American College of Chest Physicians   +7 more
doaj  

STAMP: surgical thromboprophylaxis adherence management programme

BMJ Open Quality
Introduction Venous thromboembolism is the main cause of preventable in-hospital morbidity and mortality. Despite the recommendations available in the clinical practice guideline, there is low adherence to correct thromboprophylaxis.
Natalia Quintana-Montejo, Paulo Andres Cabrera Rivera, Stefany de Jesús Ríos Acuña, Danna Lesley Cruz Reyes   +3 more
doaj   +1 more source

Thromb Res [PDF]

Fondaparinux is an antithrombin-dependent factor Xa inhibitor that is used for thromboprophylaxis of patients undergoing hip fracture surgery, hip or knee replacement, or abdominal surgery.

core  

Thromboprophylaxis in Cancer Patients Undergoing Surgery

, 2017
Venous thromboembolism (VTE) is a common, complex, and costly complication in cancer patients undergoing surgery. VTE risk varies with types of cancer surgery as well as patient-, cancer-, and treatment-associated factors. Current VTE preventive measures
Kay Htun, Agnes Lee
core   +1 more source

Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis

World Journal of Surgical Oncology
Background Direct oral anticoagulants (DOACs) used as an alternative to low-molecular-weight heparin (LMWH) for thromboprophylaxis after cancer surgery for venous thromboembolic events (VTE) remains unclear.
Hong Zhou, Ting-Ting Chen, Ling-ling Ye, Jun-Jie Ma, Jin-Hua Zhang   +4 more
doaj   +1 more source

Omission of early thromboprophylaxis and mortality in critically ill patients

, 2011
Background VTE is a preventable cause of death within hospitals. This study aimed to assess the association between omission of early thromboprophylaxis for > 24 h after ICU admission and mortality in critically ill patients.
Kwok M. Ho, David Pilcher, Shaila Chavan, Pilcher, D., Chavan, S., Ho, K.M.   +5 more
core   +1 more source